MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Part of paid clinical trials in Portland, Oregon.

Sponsor
OHSU Knight Cancer Institute
Study ID
NCT04996316
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
FEMALE
Age
40 Years - 74 Years
Healthy Volunteers
Accepted

Interventions

  • Electronic Health Record Review — OTHER
    Health record reviewed
  • Interview — OTHER
    Participate in interview
  • Media Intervention — OTHER
    Use MammoScreen
  • Survey Administration — OTHER
    Complete survey
  • Training and Education — OTHER
    Undergo training

Study Details

This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.

Key Dates

Start date
Sep 7, 2022
Status verified
Feb 2026
Primary completion
Apr 30, 2025
Completion
Aug 31, 2026

Study Design

Enrollment
1,141 participants (estimated)

Arms

  • Arm: Clinical staff (interview, training, survey)
    Before implementation, some participants will complete usability testing of the interface in the electronic health record and MammoScreen. Participants undergo training sessions over 20 minutes and participate in interviews over 30 minutes at baseline, prior to MammoScreen launch. Clinical staff also participate in interviews over 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase, about six months after the last reminders are sent.
  • Arm: Patients (interview, MammoScreen)
    Patients participate in interviews up to 1 hour. Patients medical records are reviewed. Patients use the MammoScreen at enrollment. Some Patients will also participate in interviews up to 1 hour, each during years 3-5.

Primary Outcome Measure

Uptake of MammoScreen [ Time Frame: Up to 5 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
OHSU Knight Cancer InstitutePortlandOregon97239-

Find similar trials in Portland, OR

By condition

Related Studies